Cancer News and Research

Latest Cancer News and Research

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster University-led study.

10 Nov 2022

Copper and copper-binding proteins could be potential targets for cancer treatment

For cancer cells to grow and spread around the human body, they need proteins that bind copper ions. New research about how cancer-related proteins bind the metal and how they interact with other proteins, opens up potential new drug targets in the fight against cancer.

10 Nov 2022

MicroRNAs can upregulate proteins in addition to downregulating protein production

microRNAs can play a role in cancer development and are thought to exclusively suppress protein expression in dividing cells, such as tumor cells.

10 Nov 2022

Pain disparities among racial and ethnic groups in the U.S. are far larger than previously understood

Racial and ethnic disparities in pain prevalence in the U.S. are far larger than previously realized, according to the results of a new study co-written by a University at Buffalo medical sociologist.

9 Nov 2022

Researchers discover residual tumor cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum.

9 Nov 2022

New tool maps how breast cancer grows in previously unseen detail

New technology can trace which populations of breast cancer cells are responsible for the spread of the disease, and for the first time highlights how the location of cancer cells could be as important as mutations in tumor growth.

9 Nov 2022

Pioneering research identifies a promising treatment approach for myelofibrosis

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

9 Nov 2022

Study links ultra-processed food consumption to premature death

The results of a new study depicted that ultra-processed food (UPF) consumption precipitated premature deaths in Brazil.

9 Nov 2022

More babies, lower risk of endometrial cancer

While many highly industrialized and developed countries report falling or negative population growth rates due to a rapid decrease in the number of babies born each year, a new report adds more strength to the evidence that bearing a baby has a protective effect on the endometrium, the lining of the womb, reducing the risk of endometrial cancer.

8 Nov 2022

Food sustainability incorporated in only 20% of European food-based dietary guidelines

The health of the planet and that of humankind are profoundly interconnected: the way we feed ourselves has a significant impact upon both our own health and that of the environment.

8 Nov 2022

Protein complex may present strong therapeutic target for lethal breast cancer

Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that a protein complex that governs gene expression (called CoREST) sometimes gets rewired during breast cancer to help estrogen receptor positive (ER+) tumors resist endocrine therapies and become more aggressive.

8 Nov 2022

Cell competition could be responsible for cancer relapses, study shows

A normal process called cell competition, in which healthy tissues eliminate unhealthy cells, could be responsible for cancer relapses in patients months or years after they were declared cancer-free, a new study by UT Southwestern Simmons Cancer Center researchers suggests.

8 Nov 2022

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no significant difference in cancer risk in patients with rheumatic disease and a history of malignancy taking biologic or targeted synthetic DMARDs compared to those treated with TNF inhibitors.

8 Nov 2022

New breakthrough could help spot lung cancer earlier and improve patient outcomes

Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease.

8 Nov 2022

Genetic variant associated with slimness estimated to be present in almost 60% of the Europeans

How much do genes influence our body weight? For the general population this influence is around 20%, according to studies that in recent years have analyzed the complete genome of tens of thousands of people.

8 Nov 2022

Scientists develop new electrochemical sensing platform to monitor vascularized tissue model

The costliness of drug development and the limitations of studying physiological processes in the lab are two separate scientific issues that may share the same solution.

8 Nov 2022

Cancer drugs work better after vaccination with the Chinese Covid vaccine

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor.

8 Nov 2022

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

MGI, a company committed to building core tools and technology to lead life science, today announced the launch of its new Customer Experience Center (CEC) in Berlin, Germany.

From MGI 8 Nov 2022

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay but also has the option of using a regular pharmacy through Tricare, the Defense Department's private health care program.

8 Nov 2022

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Researchers at the University of Maryland School of Medicine's (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart.

8 Nov 2022

Cancer News and Research

Latest Cancer News and Research

Enzyme that drives growth of medulloblastoma may hold the key to future treatment

Copper and copper-binding proteins could be potential targets for cancer treatment

MicroRNAs can upregulate proteins in addition to downregulating protein production

Pain disparities among racial and ethnic groups in the U.S. are far larger than previously understood

Researchers discover residual tumor cells responsible for colon cancer relapse

New tool maps how breast cancer grows in previously unseen detail

Pioneering research identifies a promising treatment approach for myelofibrosis

Study links ultra-processed food consumption to premature death

More babies, lower risk of endometrial cancer

Food sustainability incorporated in only 20% of European food-based dietary guidelines

Protein complex may present strong therapeutic target for lethal breast cancer

Cell competition could be responsible for cancer relapses, study shows

Study: No significant difference in cancer risk in rheumatology patients with history of malignancy taking DMARDs

New breakthrough could help spot lung cancer earlier and improve patient outcomes

Genetic variant associated with slimness estimated to be present in almost 60% of the Europeans

Scientists develop new electrochemical sensing platform to monitor vascularized tissue model

Cancer drugs work better after vaccination with the Chinese Covid vaccine

MGI Partners with ALACRiS Theranostics to Open New Customer Experience Center in Germany

Defense department health plan cuts its pharmacy network by nearly 15,000 outlets

Study identifies a potential pharmacological target for treating COVID-19-associated heart failure

Industry Focus: Cell & Gene Therapy eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in